nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—Sulfonylurea Compounds—Tolazamide—type 2 diabetes mellitus	0.0608	0.21	CiPCiCtD
Glipizide—Sulfonylurea Compounds—Chlorpropamide—type 2 diabetes mellitus	0.0608	0.21	CiPCiCtD
Glipizide—Sulfonylurea Compounds—Glimepiride—type 2 diabetes mellitus	0.0608	0.21	CiPCiCtD
Glipizide—Sulfonylurea Compounds—Tolbutamide—type 2 diabetes mellitus	0.0608	0.21	CiPCiCtD
Glipizide—ABCC8—type 2 diabetes mellitus	0.049	0.442	CbGaD
Glipizide—Sulfonylurea Compounds—Glyburide—type 2 diabetes mellitus	0.0461	0.159	CiPCiCtD
Glipizide—Tolazamide—type 2 diabetes mellitus	0.0425	0.185	CrCtD
Glipizide—Glimepiride—type 2 diabetes mellitus	0.0425	0.185	CrCtD
Glipizide—Gliclazide—type 2 diabetes mellitus	0.0403	0.175	CrCtD
Glipizide—Tolbutamide—type 2 diabetes mellitus	0.0403	0.175	CrCtD
Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.0369	0.16	CrCtD
Glipizide—KCNJ11—type 2 diabetes mellitus	0.0345	0.311	CbGaD
Glipizide—Glyburide—type 2 diabetes mellitus	0.0279	0.121	CrCtD
Glipizide—PPARG—type 2 diabetes mellitus	0.0191	0.173	CbGaD
Glipizide—ABCC8—Tolazamide—type 2 diabetes mellitus	0.0117	0.0742	CbGbCtD
Glipizide—ABCC8—Glimepiride—type 2 diabetes mellitus	0.0104	0.0661	CbGbCtD
Glipizide—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0101	0.0641	CbGbCtD
Glipizide—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.00901	0.0572	CbGbCtD
Glipizide—ABCC8—Gliclazide—type 2 diabetes mellitus	0.00887	0.0562	CbGbCtD
Glipizide—Gliquidone—Glimepiride—type 2 diabetes mellitus	0.00858	0.0567	CrCrCtD
Glipizide—ABCC8—Repaglinide—type 2 diabetes mellitus	0.00834	0.0529	CbGbCtD
Glipizide—PPARG—Repaglinide—type 2 diabetes mellitus	0.00834	0.0529	CbGbCtD
Glipizide—CYP3A4—type 2 diabetes mellitus	0.00824	0.0744	CbGaD
Glipizide—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.00766	0.0486	CbGbCtD
Glipizide—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.00754	0.0478	CbGbCtD
Glipizide—PPARG—Pioglitazone—type 2 diabetes mellitus	0.00754	0.0478	CbGbCtD
Glipizide—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.0072	0.0457	CbGbCtD
Glipizide—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.00696	0.0441	CbGbCtD
Glipizide—ABCC8—Tolbutamide—type 2 diabetes mellitus	0.00672	0.0426	CbGbCtD
Glipizide—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.00652	0.0413	CbGbCtD
Glipizide—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.00581	0.0368	CbGbCtD
Glipizide—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00571	0.0362	CbGbCtD
Glipizide—PPARG—Nateglinide—type 2 diabetes mellitus	0.00571	0.0362	CbGbCtD
Glipizide—Gliquidone—Glyburide—type 2 diabetes mellitus	0.00564	0.0372	CrCrCtD
Glipizide—Glimepiride—Gliclazide—type 2 diabetes mellitus	0.0052	0.0343	CrCrCtD
Glipizide—Tolazamide—Tolbutamide—type 2 diabetes mellitus	0.0052	0.0343	CrCrCtD
Glipizide—Tolazamide—Gliclazide—type 2 diabetes mellitus	0.0052	0.0343	CrCrCtD
Glipizide—Glimepiride—Tolbutamide—type 2 diabetes mellitus	0.0052	0.0343	CrCrCtD
Glipizide—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00494	0.0313	CbGbCtD
Glipizide—Gliclazide—Glimepiride—type 2 diabetes mellitus	0.00493	0.0326	CrCrCtD
Glipizide—Gliclazide—Tolazamide—type 2 diabetes mellitus	0.00493	0.0326	CrCrCtD
Glipizide—Tolbutamide—Glimepiride—type 2 diabetes mellitus	0.00493	0.0326	CrCrCtD
Glipizide—Tolbutamide—Tolazamide—type 2 diabetes mellitus	0.00493	0.0326	CrCrCtD
Glipizide—Glimepiride—Chlorpropamide—type 2 diabetes mellitus	0.00476	0.0314	CrCrCtD
Glipizide—Tolazamide—Chlorpropamide—type 2 diabetes mellitus	0.00476	0.0314	CrCrCtD
Glipizide—Tolbutamide—Gliclazide—type 2 diabetes mellitus	0.00467	0.0309	CrCrCtD
Glipizide—Gliclazide—Tolbutamide—type 2 diabetes mellitus	0.00467	0.0309	CrCrCtD
Glipizide—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.00449	0.0296	CrCrCtD
Glipizide—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.00449	0.0296	CrCrCtD
Glipizide—Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.00427	0.0282	CrCrCtD
Glipizide—Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.00427	0.0282	CrCrCtD
Glipizide—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.00425	0.0281	CrCrCtD
Glipizide—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.00425	0.0281	CrCrCtD
Glipizide—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.00412	0.0272	CrCrCtD
Glipizide—Glyburide—Glimepiride—type 2 diabetes mellitus	0.00412	0.0272	CrCrCtD
Glipizide—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.00412	0.0272	CrCrCtD
Glipizide—Glyburide—Tolazamide—type 2 diabetes mellitus	0.00412	0.0272	CrCrCtD
Glipizide—Glyburide—Gliclazide—type 2 diabetes mellitus	0.00391	0.0258	CrCrCtD
Glipizide—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.00391	0.0258	CrCrCtD
Glipizide—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.00391	0.0258	CrCrCtD
Glipizide—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.00389	0.0257	CrCrCtD
Glipizide—ABCC8—Glyburide—type 2 diabetes mellitus	0.00386	0.0245	CbGbCtD
Glipizide—Glimepiride—Glyburide—type 2 diabetes mellitus	0.0036	0.0238	CrCrCtD
Glipizide—Tolazamide—Glyburide—type 2 diabetes mellitus	0.0036	0.0238	CrCrCtD
Glipizide—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00358	0.0236	CrCrCtD
Glipizide—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00334	0.0212	CbGbCtD
Glipizide—Gliclazide—Glyburide—type 2 diabetes mellitus	0.00324	0.0214	CrCrCtD
Glipizide—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.00295	0.0195	CrCrCtD
Glipizide—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.00271	0.0179	CrCrCtD
Glipizide—ABCC8—penis—type 2 diabetes mellitus	0.00111	0.17	CbGeAlD
Glipizide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00106	0.00671	CbGbCtD
Glipizide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.000899	0.00571	CbGbCtD
Glipizide—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.000888	0.136	CbGeAlD
Glipizide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.000765	0.00485	CbGbCtD
Glipizide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.000765	0.00485	CbGbCtD
Glipizide—PPARG—leg—type 2 diabetes mellitus	0.000714	0.11	CbGeAlD
Glipizide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.000706	0.00448	CbGbCtD
Glipizide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00069	0.00438	CbGbCtD
Glipizide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.000682	0.00432	CbGbCtD
Glipizide—PPARG—hindlimb—type 2 diabetes mellitus	0.000638	0.098	CbGeAlD
Glipizide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.000623	0.00395	CbGbCtD
Glipizide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.000615	0.0039	CbGbCtD
Glipizide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00058	0.00368	CbGbCtD
Glipizide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.000556	0.00352	CbGbCtD
Glipizide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.000492	0.00312	CbGbCtD
Glipizide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.000445	0.00282	CbGbCtD
Glipizide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.000391	0.00248	CbGbCtD
Glipizide—PPARG—artery—type 2 diabetes mellitus	0.000391	0.0601	CbGeAlD
Glipizide—CYP2C9—Losartan—type 2 diabetes mellitus	0.000358	0.00227	CbGbCtD
Glipizide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.000337	0.00214	CbGbCtD
Glipizide—PPARG—endothelium—type 2 diabetes mellitus	0.00033	0.0508	CbGeAlD
Glipizide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.000323	0.00205	CbGbCtD
Glipizide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.000323	0.00205	CbGbCtD
Glipizide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00194	CbGbCtD
Glipizide—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000267	0.0411	CbGeAlD
Glipizide—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000246	0.0378	CbGeAlD
Glipizide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000228	0.00144	CbGbCtD
Glipizide—CYP3A4—Losartan—type 2 diabetes mellitus	0.000208	0.00132	CbGbCtD
Glipizide—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000193	0.0297	CbGeAlD
Glipizide—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000188	0.0289	CbGeAlD
Glipizide—KCNJ11—pancreas—type 2 diabetes mellitus	0.000188	0.0289	CbGeAlD
Glipizide—ABCC8—cardiovascular system—type 2 diabetes mellitus	0.000178	0.0274	CbGeAlD
Glipizide—ABCC8—kidney—type 2 diabetes mellitus	0.000174	0.0268	CbGeAlD
Glipizide—ABCC8—pancreas—type 2 diabetes mellitus	0.000173	0.0266	CbGeAlD
Glipizide—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000136	0.0209	CbGeAlD
Glipizide—PPARG—kidney—type 2 diabetes mellitus	0.000133	0.0204	CbGeAlD
Glipizide—PPARG—pancreas—type 2 diabetes mellitus	0.000132	0.0203	CbGeAlD
Glipizide—PPARG—adipose tissue—type 2 diabetes mellitus	0.00012	0.0184	CbGeAlD
Glipizide—Gliquidone—ABCC8—type 2 diabetes mellitus	0.000117	0.105	CrCbGaD
Glipizide—Tolazamide—ABCC8—type 2 diabetes mellitus	9.38e-05	0.0837	CrCbGaD
Glipizide—Glisoxepide—ABCC8—type 2 diabetes mellitus	8.48e-05	0.0757	CrCbGaD
Glipizide—PPARG—liver—type 2 diabetes mellitus	8.41e-05	0.0129	CbGeAlD
Glipizide—Glimepiride—ABCC8—type 2 diabetes mellitus	8.36e-05	0.0746	CrCbGaD
Glipizide—Gliquidone—KCNJ11—type 2 diabetes mellitus	8.27e-05	0.0738	CrCbGaD
Glipizide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.96e-05	0.0122	CbGeAlD
Glipizide—Gliclazide—ABCC8—type 2 diabetes mellitus	6.74e-05	0.0601	CrCbGaD
Glipizide—Tolazamide—KCNJ11—type 2 diabetes mellitus	6.61e-05	0.059	CrCbGaD
Glipizide—Glisoxepide—KCNJ11—type 2 diabetes mellitus	5.98e-05	0.0533	CrCbGaD
Glipizide—CYP3A4—kidney—type 2 diabetes mellitus	5.94e-05	0.00912	CbGeAlD
Glipizide—Glimepiride—KCNJ11—type 2 diabetes mellitus	5.89e-05	0.0526	CrCbGaD
Glipizide—Chlorpropamide—ABCC8—type 2 diabetes mellitus	5.24e-05	0.0468	CrCbGaD
Glipizide—Tolbutamide—ABCC8—type 2 diabetes mellitus	5.11e-05	0.0456	CrCbGaD
Glipizide—Glyburide—CPT1A—type 2 diabetes mellitus	5.11e-05	0.0456	CrCbGaD
Glipizide—CYP2C9—liver—type 2 diabetes mellitus	4.92e-05	0.00756	CbGeAlD
Glipizide—Gliclazide—KCNJ11—type 2 diabetes mellitus	4.75e-05	0.0424	CrCbGaD
Glipizide—CYP3A4—liver—type 2 diabetes mellitus	3.75e-05	0.00577	CbGeAlD
Glipizide—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	3.69e-05	0.0329	CrCbGaD
Glipizide—Gliclazide—VEGFA—type 2 diabetes mellitus	3.68e-05	0.0328	CrCbGaD
Glipizide—Tolbutamide—KCNJ11—type 2 diabetes mellitus	3.6e-05	0.0321	CrCbGaD
Glipizide—Glyburide—ABCC8—type 2 diabetes mellitus	3.54e-05	0.0316	CrCbGaD
Glipizide—Glyburide—KCNJ11—type 2 diabetes mellitus	2.49e-05	0.0223	CrCbGaD
Glipizide—Hypertension—Metformin—type 2 diabetes mellitus	1.37e-05	0.000375	CcSEcCtD
Glipizide—Urticaria—Glyburide—type 2 diabetes mellitus	1.37e-05	0.000375	CcSEcCtD
Glipizide—Nervousness—Losartan—type 2 diabetes mellitus	1.37e-05	0.000375	CcSEcCtD
Glipizide—Abdominal pain—Glyburide—type 2 diabetes mellitus	1.36e-05	0.000373	CcSEcCtD
Glipizide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	1.36e-05	0.000373	CcSEcCtD
Glipizide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	1.36e-05	0.000372	CcSEcCtD
Glipizide—Anorexia—Valsartan—type 2 diabetes mellitus	1.35e-05	0.000371	CcSEcCtD
Glipizide—Muscle spasms—Losartan—type 2 diabetes mellitus	1.35e-05	0.000371	CcSEcCtD
Glipizide—Asthenia—Bromocriptine—type 2 diabetes mellitus	1.35e-05	0.000371	CcSEcCtD
Glipizide—Myalgia—Metformin—type 2 diabetes mellitus	1.35e-05	0.00037	CcSEcCtD
Glipizide—Malaise—Irbesartan—type 2 diabetes mellitus	1.35e-05	0.00037	CcSEcCtD
Glipizide—Glyburide—ABCC2—type 2 diabetes mellitus	1.35e-05	0.012	CrCbGaD
Glipizide—Vertigo—Irbesartan—type 2 diabetes mellitus	1.34e-05	0.000369	CcSEcCtD
Glipizide—Headache—Pioglitazone—type 2 diabetes mellitus	1.34e-05	0.000368	CcSEcCtD
Glipizide—Syncope—Irbesartan—type 2 diabetes mellitus	1.34e-05	0.000368	CcSEcCtD
Glipizide—Leukopenia—Irbesartan—type 2 diabetes mellitus	1.34e-05	0.000367	CcSEcCtD
Glipizide—Visual impairment—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000367	CcSEcCtD
Glipizide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	1.34e-05	0.000366	CcSEcCtD
Glipizide—Discomfort—Metformin—type 2 diabetes mellitus	1.33e-05	0.000366	CcSEcCtD
Glipizide—Vomiting—Glimepiride—type 2 diabetes mellitus	1.33e-05	0.000364	CcSEcCtD
Glipizide—Vision blurred—Losartan—type 2 diabetes mellitus	1.33e-05	0.000364	CcSEcCtD
Glipizide—Vomiting—Sitagliptin—type 2 diabetes mellitus	1.32e-05	0.000363	CcSEcCtD
Glipizide—Constipation—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.000363	CcSEcCtD
Glipizide—Pain—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.000363	CcSEcCtD
Glipizide—Tremor—Losartan—type 2 diabetes mellitus	1.32e-05	0.000362	CcSEcCtD
Glipizide—Rash—Glimepiride—type 2 diabetes mellitus	1.32e-05	0.000361	CcSEcCtD
Glipizide—Dermatitis—Glimepiride—type 2 diabetes mellitus	1.32e-05	0.000361	CcSEcCtD
Glipizide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	1.32e-05	0.000361	CcSEcCtD
Glipizide—Rash—Sitagliptin—type 2 diabetes mellitus	1.31e-05	0.00036	CcSEcCtD
Glipizide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	1.31e-05	0.00036	CcSEcCtD
Glipizide—Headache—Glimepiride—type 2 diabetes mellitus	1.31e-05	0.000359	CcSEcCtD
Glipizide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	1.31e-05	0.000358	CcSEcCtD
Glipizide—Headache—Sitagliptin—type 2 diabetes mellitus	1.3e-05	0.000358	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	1.29e-05	0.000355	CcSEcCtD
Glipizide—Oedema—Metformin—type 2 diabetes mellitus	1.29e-05	0.000355	CcSEcCtD
Glipizide—Hypertension—Irbesartan—type 2 diabetes mellitus	1.29e-05	0.000354	CcSEcCtD
Glipizide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.29e-05	0.000353	CcSEcCtD
Glipizide—Flushing—Ramipril—type 2 diabetes mellitus	1.29e-05	0.000353	CcSEcCtD
Glipizide—Insomnia—Valsartan—type 2 diabetes mellitus	1.29e-05	0.000352	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.28e-05	0.000351	CcSEcCtD
Glipizide—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.28e-05	0.00035	CcSEcCtD
Glipizide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.27e-05	0.000349	CcSEcCtD
Glipizide—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000349	CcSEcCtD
Glipizide—Myalgia—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000349	CcSEcCtD
Glipizide—Shock—Metformin—type 2 diabetes mellitus	1.27e-05	0.000349	CcSEcCtD
Glipizide—Insomnia—Orlistat—type 2 diabetes mellitus	1.27e-05	0.000348	CcSEcCtD
Glipizide—Malaise—Losartan—type 2 diabetes mellitus	1.27e-05	0.000348	CcSEcCtD
Glipizide—Anxiety—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000348	CcSEcCtD
Glipizide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.27e-05	0.000348	CcSEcCtD
Glipizide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.27e-05	0.000347	CcSEcCtD
Glipizide—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.27e-05	0.000347	CcSEcCtD
Glipizide—Vertigo—Losartan—type 2 diabetes mellitus	1.27e-05	0.000347	CcSEcCtD
Glipizide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.26e-05	0.000347	CcSEcCtD
Glipizide—Somnolence—Valsartan—type 2 diabetes mellitus	1.26e-05	0.000346	CcSEcCtD
Glipizide—Syncope—Losartan—type 2 diabetes mellitus	1.26e-05	0.000346	CcSEcCtD
Glipizide—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.26e-05	0.000346	CcSEcCtD
Glipizide—Leukopenia—Losartan—type 2 diabetes mellitus	1.26e-05	0.000346	CcSEcCtD
Glipizide—Discomfort—Irbesartan—type 2 diabetes mellitus	1.26e-05	0.000345	CcSEcCtD
Glipizide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.25e-05	0.000343	CcSEcCtD
Glipizide—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.25e-05	0.000343	CcSEcCtD
Glipizide—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.25e-05	0.000342	CcSEcCtD
Glipizide—Nausea—Glimepiride—type 2 diabetes mellitus	1.24e-05	0.00034	CcSEcCtD
Glipizide—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.24e-05	0.00034	CcSEcCtD
Glipizide—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.24e-05	0.000339	CcSEcCtD
Glipizide—Nausea—Sitagliptin—type 2 diabetes mellitus	1.24e-05	0.000339	CcSEcCtD
Glipizide—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.24e-05	0.000339	CcSEcCtD
Glipizide—Asthenia—Glyburide—type 2 diabetes mellitus	1.24e-05	0.000339	CcSEcCtD
Glipizide—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.24e-05	0.000339	CcSEcCtD
Glipizide—Anorexia—Metformin—type 2 diabetes mellitus	1.23e-05	0.000338	CcSEcCtD
Glipizide—Urticaria—Gliclazide—type 2 diabetes mellitus	1.23e-05	0.000337	CcSEcCtD
Glipizide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.23e-05	0.000336	CcSEcCtD
Glipizide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.22e-05	0.000335	CcSEcCtD
Glipizide—Oedema—Irbesartan—type 2 diabetes mellitus	1.22e-05	0.000335	CcSEcCtD
Glipizide—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.22e-05	0.000335	CcSEcCtD
Glipizide—Pruritus—Glyburide—type 2 diabetes mellitus	1.22e-05	0.000334	CcSEcCtD
Glipizide—Constipation—Valsartan—type 2 diabetes mellitus	1.22e-05	0.000333	CcSEcCtD
Glipizide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.21e-05	0.000332	CcSEcCtD
Glipizide—Erythema—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000331	CcSEcCtD
Glipizide—Shock—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.000329	CcSEcCtD
Glipizide—Pain—Orlistat—type 2 diabetes mellitus	1.2e-05	0.000329	CcSEcCtD
Glipizide—Myalgia—Losartan—type 2 diabetes mellitus	1.2e-05	0.000329	CcSEcCtD
Glipizide—Arthralgia—Losartan—type 2 diabetes mellitus	1.2e-05	0.000329	CcSEcCtD
Glipizide—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.2e-05	0.000328	CcSEcCtD
Glipizide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.000328	CcSEcCtD
Glipizide—Anxiety—Losartan—type 2 diabetes mellitus	1.19e-05	0.000328	CcSEcCtD
Glipizide—Rash—Bromocriptine—type 2 diabetes mellitus	1.19e-05	0.000326	CcSEcCtD
Glipizide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.19e-05	0.000325	CcSEcCtD
Glipizide—Tension—Ramipril—type 2 diabetes mellitus	1.18e-05	0.000325	CcSEcCtD
Glipizide—Discomfort—Losartan—type 2 diabetes mellitus	1.18e-05	0.000325	CcSEcCtD
Glipizide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.18e-05	0.000324	CcSEcCtD
Glipizide—Headache—Bromocriptine—type 2 diabetes mellitus	1.18e-05	0.000324	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.18e-05	0.000323	CcSEcCtD
Glipizide—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.18e-05	0.000323	CcSEcCtD
Glipizide—Nervousness—Ramipril—type 2 diabetes mellitus	1.17e-05	0.000322	CcSEcCtD
Glipizide—Anorexia—Irbesartan—type 2 diabetes mellitus	1.16e-05	0.000319	CcSEcCtD
Glipizide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.16e-05	0.000319	CcSEcCtD
Glipizide—Paraesthesia—Metformin—type 2 diabetes mellitus	1.16e-05	0.000319	CcSEcCtD
Glipizide—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000318	CcSEcCtD
Glipizide—Confusional state—Losartan—type 2 diabetes mellitus	1.16e-05	0.000318	CcSEcCtD
Glipizide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.16e-05	0.000317	CcSEcCtD
Glipizide—Dyspnoea—Metformin—type 2 diabetes mellitus	1.15e-05	0.000316	CcSEcCtD
Glipizide—Somnolence—Metformin—type 2 diabetes mellitus	1.15e-05	0.000315	CcSEcCtD
Glipizide—Oedema—Losartan—type 2 diabetes mellitus	1.15e-05	0.000315	CcSEcCtD
Glipizide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.15e-05	0.000315	CcSEcCtD
Glipizide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.14e-05	0.000312	CcSEcCtD
Glipizide—Dyspepsia—Metformin—type 2 diabetes mellitus	1.14e-05	0.000312	CcSEcCtD
Glipizide—Tremor—Ramipril—type 2 diabetes mellitus	1.13e-05	0.00031	CcSEcCtD
Glipizide—Shock—Losartan—type 2 diabetes mellitus	1.13e-05	0.00031	CcSEcCtD
Glipizide—Urticaria—Valsartan—type 2 diabetes mellitus	1.13e-05	0.00031	CcSEcCtD
Glipizide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.13e-05	0.000309	CcSEcCtD
Glipizide—Decreased appetite—Metformin—type 2 diabetes mellitus	1.12e-05	0.000308	CcSEcCtD
Glipizide—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.12e-05	0.000308	CcSEcCtD
Glipizide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000307	CcSEcCtD
Glipizide—Nausea—Bromocriptine—type 2 diabetes mellitus	1.12e-05	0.000307	CcSEcCtD
Glipizide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.12e-05	0.000306	CcSEcCtD
Glipizide—Urticaria—Orlistat—type 2 diabetes mellitus	1.12e-05	0.000306	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.11e-05	0.000305	CcSEcCtD
Glipizide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.11e-05	0.000305	CcSEcCtD
Glipizide—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.11e-05	0.000304	CcSEcCtD
Glipizide—Asthenia—Gliclazide—type 2 diabetes mellitus	1.11e-05	0.000304	CcSEcCtD
Glipizide—Constipation—Metformin—type 2 diabetes mellitus	1.11e-05	0.000303	CcSEcCtD
Glipizide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000301	CcSEcCtD
Glipizide—Anorexia—Losartan—type 2 diabetes mellitus	1.1e-05	0.0003	CcSEcCtD
Glipizide—Vomiting—Glyburide—type 2 diabetes mellitus	1.1e-05	0.0003	CcSEcCtD
Glipizide—Pruritus—Gliclazide—type 2 diabetes mellitus	1.09e-05	0.0003	CcSEcCtD
Glipizide—Malaise—Ramipril—type 2 diabetes mellitus	1.09e-05	0.000299	CcSEcCtD
Glipizide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000299	CcSEcCtD
Glipizide—Rash—Glyburide—type 2 diabetes mellitus	1.09e-05	0.000298	CcSEcCtD
Glipizide—Somnolence—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000298	CcSEcCtD
Glipizide—Dermatitis—Glyburide—type 2 diabetes mellitus	1.09e-05	0.000298	CcSEcCtD
Glipizide—Vertigo—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000297	CcSEcCtD
Glipizide—Syncope—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000297	CcSEcCtD
Glipizide—Leukopenia—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000296	CcSEcCtD
Glipizide—Headache—Glyburide—type 2 diabetes mellitus	1.08e-05	0.000296	CcSEcCtD
Glipizide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000295	CcSEcCtD
Glipizide—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.07e-05	0.000292	CcSEcCtD
Glipizide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.06e-05	0.000291	CcSEcCtD
Glipizide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000291	CcSEcCtD
Glipizide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.06e-05	0.00029	CcSEcCtD
Glipizide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.06e-05	0.00029	CcSEcCtD
Glipizide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.05e-05	0.000289	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.05e-05	0.000287	CcSEcCtD
Glipizide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.05e-05	0.000287	CcSEcCtD
Glipizide—Pain—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000286	CcSEcCtD
Glipizide—Constipation—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000286	CcSEcCtD
Glipizide—Insomnia—Losartan—type 2 diabetes mellitus	1.04e-05	0.000285	CcSEcCtD
Glipizide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000284	CcSEcCtD
Glipizide—Paraesthesia—Losartan—type 2 diabetes mellitus	1.03e-05	0.000283	CcSEcCtD
Glipizide—Urticaria—Metformin—type 2 diabetes mellitus	1.03e-05	0.000282	CcSEcCtD
Glipizide—Arthralgia—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000282	CcSEcCtD
Glipizide—Myalgia—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000282	CcSEcCtD
Glipizide—Dyspnoea—Losartan—type 2 diabetes mellitus	1.02e-05	0.000281	CcSEcCtD
Glipizide—Anxiety—Ramipril—type 2 diabetes mellitus	1.02e-05	0.000281	CcSEcCtD
Glipizide—Nausea—Glyburide—type 2 diabetes mellitus	1.02e-05	0.000281	CcSEcCtD
Glipizide—Abdominal pain—Metformin—type 2 diabetes mellitus	1.02e-05	0.00028	CcSEcCtD
Glipizide—Dizziness—Gliclazide—type 2 diabetes mellitus	1.02e-05	0.00028	CcSEcCtD
Glipizide—Somnolence—Losartan—type 2 diabetes mellitus	1.02e-05	0.00028	CcSEcCtD
Glipizide—Asthenia—Valsartan—type 2 diabetes mellitus	1.02e-05	0.00028	CcSEcCtD
Glipizide—Discomfort—Ramipril—type 2 diabetes mellitus	1.02e-05	0.000278	CcSEcCtD
Glipizide—Dyspepsia—Losartan—type 2 diabetes mellitus	1.01e-05	0.000277	CcSEcCtD
Glipizide—Asthenia—Orlistat—type 2 diabetes mellitus	1.01e-05	0.000276	CcSEcCtD
Glipizide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000276	CcSEcCtD
Glipizide—Pruritus—Valsartan—type 2 diabetes mellitus	1.01e-05	0.000276	CcSEcCtD
Glipizide—Decreased appetite—Losartan—type 2 diabetes mellitus	9.99e-06	0.000274	CcSEcCtD
Glipizide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.99e-06	0.000274	CcSEcCtD
Glipizide—Confusional state—Ramipril—type 2 diabetes mellitus	9.94e-06	0.000272	CcSEcCtD
Glipizide—Pruritus—Orlistat—type 2 diabetes mellitus	9.93e-06	0.000272	CcSEcCtD
Glipizide—Gliclazide—ALB—type 2 diabetes mellitus	9.9e-06	0.00883	CrCbGaD
Glipizide—Oedema—Ramipril—type 2 diabetes mellitus	9.85e-06	0.00027	CcSEcCtD
Glipizide—Vomiting—Gliclazide—type 2 diabetes mellitus	9.83e-06	0.00027	CcSEcCtD
Glipizide—Pain—Losartan—type 2 diabetes mellitus	9.83e-06	0.000269	CcSEcCtD
Glipizide—Constipation—Losartan—type 2 diabetes mellitus	9.83e-06	0.000269	CcSEcCtD
Glipizide—Rash—Gliclazide—type 2 diabetes mellitus	9.75e-06	0.000267	CcSEcCtD
Glipizide—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.74e-06	0.000267	CcSEcCtD
Glipizide—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.72e-06	0.000267	CcSEcCtD
Glipizide—Urticaria—Irbesartan—type 2 diabetes mellitus	9.7e-06	0.000266	CcSEcCtD
Glipizide—Shock—Ramipril—type 2 diabetes mellitus	9.69e-06	0.000266	CcSEcCtD
Glipizide—Headache—Gliclazide—type 2 diabetes mellitus	9.69e-06	0.000266	CcSEcCtD
Glipizide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.65e-06	0.000265	CcSEcCtD
Glipizide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.65e-06	0.000265	CcSEcCtD
Glipizide—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.61e-06	0.000263	CcSEcCtD
Glipizide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.53e-06	0.000261	CcSEcCtD
Glipizide—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.47e-06	0.00026	CcSEcCtD
Glipizide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.4e-06	0.000258	CcSEcCtD
Glipizide—Dizziness—Valsartan—type 2 diabetes mellitus	9.4e-06	0.000258	CcSEcCtD
Glipizide—Anorexia—Ramipril—type 2 diabetes mellitus	9.39e-06	0.000258	CcSEcCtD
Glipizide—Dizziness—Orlistat—type 2 diabetes mellitus	9.29e-06	0.000255	CcSEcCtD
Glipizide—Asthenia—Metformin—type 2 diabetes mellitus	9.28e-06	0.000255	CcSEcCtD
Glipizide—Nausea—Gliclazide—type 2 diabetes mellitus	9.19e-06	0.000252	CcSEcCtD
Glipizide—Pruritus—Metformin—type 2 diabetes mellitus	9.16e-06	0.000251	CcSEcCtD
Glipizide—Urticaria—Losartan—type 2 diabetes mellitus	9.13e-06	0.00025	CcSEcCtD
Glipizide—Abdominal pain—Losartan—type 2 diabetes mellitus	9.08e-06	0.000249	CcSEcCtD
Glipizide—Vomiting—Valsartan—type 2 diabetes mellitus	9.03e-06	0.000248	CcSEcCtD
Glipizide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9e-06	0.000247	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.98e-06	0.000246	CcSEcCtD
Glipizide—Rash—Valsartan—type 2 diabetes mellitus	8.96e-06	0.000246	CcSEcCtD
Glipizide—Dermatitis—Valsartan—type 2 diabetes mellitus	8.95e-06	0.000245	CcSEcCtD
Glipizide—Vomiting—Orlistat—type 2 diabetes mellitus	8.93e-06	0.000245	CcSEcCtD
Glipizide—Insomnia—Ramipril—type 2 diabetes mellitus	8.91e-06	0.000244	CcSEcCtD
Glipizide—Headache—Valsartan—type 2 diabetes mellitus	8.9e-06	0.000244	CcSEcCtD
Glipizide—Diarrhoea—Metformin—type 2 diabetes mellitus	8.85e-06	0.000243	CcSEcCtD
Glipizide—Rash—Orlistat—type 2 diabetes mellitus	8.85e-06	0.000243	CcSEcCtD
Glipizide—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.85e-06	0.000243	CcSEcCtD
Glipizide—Dermatitis—Orlistat—type 2 diabetes mellitus	8.84e-06	0.000243	CcSEcCtD
Glipizide—Headache—Orlistat—type 2 diabetes mellitus	8.8e-06	0.000241	CcSEcCtD
Glipizide—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.79e-06	0.000241	CcSEcCtD
Glipizide—Asthenia—Irbesartan—type 2 diabetes mellitus	8.76e-06	0.00024	CcSEcCtD
Glipizide—Somnolence—Ramipril—type 2 diabetes mellitus	8.76e-06	0.00024	CcSEcCtD
Glipizide—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.67e-06	0.000238	CcSEcCtD
Glipizide—Pruritus—Irbesartan—type 2 diabetes mellitus	8.64e-06	0.000237	CcSEcCtD
Glipizide—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.57e-06	0.000235	CcSEcCtD
Glipizide—Dizziness—Metformin—type 2 diabetes mellitus	8.56e-06	0.000235	CcSEcCtD
Glipizide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.51e-06	0.000233	CcSEcCtD
Glipizide—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.47e-06	0.000232	CcSEcCtD
Glipizide—Nausea—Valsartan—type 2 diabetes mellitus	8.44e-06	0.000231	CcSEcCtD
Glipizide—Constipation—Ramipril—type 2 diabetes mellitus	8.43e-06	0.000231	CcSEcCtD
Glipizide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.36e-06	0.000229	CcSEcCtD
Glipizide—Nausea—Orlistat—type 2 diabetes mellitus	8.34e-06	0.000229	CcSEcCtD
Glipizide—Asthenia—Losartan—type 2 diabetes mellitus	8.25e-06	0.000226	CcSEcCtD
Glipizide—Vomiting—Metformin—type 2 diabetes mellitus	8.23e-06	0.000226	CcSEcCtD
Glipizide—Rash—Metformin—type 2 diabetes mellitus	8.16e-06	0.000224	CcSEcCtD
Glipizide—Dermatitis—Metformin—type 2 diabetes mellitus	8.15e-06	0.000224	CcSEcCtD
Glipizide—Pruritus—Losartan—type 2 diabetes mellitus	8.13e-06	0.000223	CcSEcCtD
Glipizide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.12e-06	0.000223	CcSEcCtD
Glipizide—Headache—Metformin—type 2 diabetes mellitus	8.11e-06	0.000222	CcSEcCtD
Glipizide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.08e-06	0.000221	CcSEcCtD
Glipizide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.06e-06	0.000221	CcSEcCtD
Glipizide—Diarrhoea—Losartan—type 2 diabetes mellitus	7.86e-06	0.000216	CcSEcCtD
Glipizide—Urticaria—Ramipril—type 2 diabetes mellitus	7.83e-06	0.000215	CcSEcCtD
Glipizide—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.79e-06	0.000214	CcSEcCtD
Glipizide—Vomiting—Irbesartan—type 2 diabetes mellitus	7.76e-06	0.000213	CcSEcCtD
Glipizide—Rash—Irbesartan—type 2 diabetes mellitus	7.7e-06	0.000211	CcSEcCtD
Glipizide—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.69e-06	0.000211	CcSEcCtD
Glipizide—Nausea—Metformin—type 2 diabetes mellitus	7.69e-06	0.000211	CcSEcCtD
Glipizide—Headache—Irbesartan—type 2 diabetes mellitus	7.65e-06	0.00021	CcSEcCtD
Glipizide—Dizziness—Losartan—type 2 diabetes mellitus	7.6e-06	0.000208	CcSEcCtD
Glipizide—Vomiting—Losartan—type 2 diabetes mellitus	7.31e-06	0.0002	CcSEcCtD
Glipizide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.26e-06	0.000199	CcSEcCtD
Glipizide—Nausea—Irbesartan—type 2 diabetes mellitus	7.25e-06	0.000199	CcSEcCtD
Glipizide—Rash—Losartan—type 2 diabetes mellitus	7.25e-06	0.000199	CcSEcCtD
Glipizide—Dermatitis—Losartan—type 2 diabetes mellitus	7.24e-06	0.000199	CcSEcCtD
Glipizide—Headache—Losartan—type 2 diabetes mellitus	7.2e-06	0.000197	CcSEcCtD
Glipizide—Asthenia—Ramipril—type 2 diabetes mellitus	7.07e-06	0.000194	CcSEcCtD
Glipizide—Pruritus—Ramipril—type 2 diabetes mellitus	6.97e-06	0.000191	CcSEcCtD
Glipizide—Nausea—Losartan—type 2 diabetes mellitus	6.83e-06	0.000187	CcSEcCtD
Glipizide—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.74e-06	0.000185	CcSEcCtD
Glipizide—Dizziness—Ramipril—type 2 diabetes mellitus	6.52e-06	0.000179	CcSEcCtD
Glipizide—Vomiting—Ramipril—type 2 diabetes mellitus	6.27e-06	0.000172	CcSEcCtD
Glipizide—Rash—Ramipril—type 2 diabetes mellitus	6.21e-06	0.00017	CcSEcCtD
Glipizide—Dermatitis—Ramipril—type 2 diabetes mellitus	6.21e-06	0.00017	CcSEcCtD
Glipizide—Headache—Ramipril—type 2 diabetes mellitus	6.17e-06	0.000169	CcSEcCtD
Glipizide—Glyburide—CYP3A4—type 2 diabetes mellitus	5.96e-06	0.00532	CrCbGaD
Glipizide—Nausea—Ramipril—type 2 diabetes mellitus	5.85e-06	0.000161	CcSEcCtD
Glipizide—Glyburide—ALB—type 2 diabetes mellitus	5.2e-06	0.00464	CrCbGaD
Glipizide—PPARG—Metabolism—SLC2A1—type 2 diabetes mellitus	2.39e-06	0.000146	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CD36—type 2 diabetes mellitus	2.38e-06	0.000146	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADCY5—type 2 diabetes mellitus	2.38e-06	0.000145	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.38e-06	0.000145	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPX1—type 2 diabetes mellitus	2.37e-06	0.000145	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.35e-06	0.000144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.35e-06	0.000144	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP3A4—type 2 diabetes mellitus	2.33e-06	0.000142	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.32e-06	0.000142	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CD36—type 2 diabetes mellitus	2.31e-06	0.000141	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC2A4—type 2 diabetes mellitus	2.29e-06	0.00014	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GCG—type 2 diabetes mellitus	2.29e-06	0.00014	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPP2CA—type 2 diabetes mellitus	2.28e-06	0.000139	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—type 2 diabetes mellitus	2.27e-06	0.000139	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—type 2 diabetes mellitus	2.26e-06	0.000138	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NFKB1—type 2 diabetes mellitus	2.25e-06	0.000138	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARA—type 2 diabetes mellitus	2.21e-06	0.000135	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.19e-06	0.000134	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.19e-06	0.000134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—type 2 diabetes mellitus	2.19e-06	0.000134	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.18e-06	0.000133	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR3C1—type 2 diabetes mellitus	2.18e-06	0.000133	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.17e-06	0.000133	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARA—type 2 diabetes mellitus	2.15e-06	0.000131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AGT—type 2 diabetes mellitus	2.14e-06	0.000131	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.14e-06	0.000131	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.12e-06	0.00013	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.12e-06	0.000129	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.12e-06	0.000129	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.12e-06	0.000129	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.12e-06	0.000129	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.12e-06	0.000129	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CALM1—type 2 diabetes mellitus	2.11e-06	0.000129	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—type 2 diabetes mellitus	2.1e-06	0.000128	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—type 2 diabetes mellitus	2.1e-06	0.000128	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AGT—type 2 diabetes mellitus	2.08e-06	0.000127	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOA1—type 2 diabetes mellitus	2.08e-06	0.000127	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.05e-06	0.000125	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-06	0.000125	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—type 2 diabetes mellitus	2.04e-06	0.000125	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PPARA—type 2 diabetes mellitus	2.04e-06	0.000125	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—type 2 diabetes mellitus	2.04e-06	0.000125	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-06	0.000123	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.98e-06	0.000121	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.97e-06	0.000121	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GNB3—type 2 diabetes mellitus	1.97e-06	0.000121	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.97e-06	0.000121	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—type 2 diabetes mellitus	1.96e-06	0.00012	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAT—type 2 diabetes mellitus	1.94e-06	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.94e-06	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.94e-06	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.89e-06	0.000115	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOB—type 2 diabetes mellitus	1.88e-06	0.000115	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.87e-06	0.000115	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—type 2 diabetes mellitus	1.84e-06	0.000112	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-06	0.000112	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—type 2 diabetes mellitus	1.83e-06	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.8e-06	0.00011	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.8e-06	0.00011	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.8e-06	0.00011	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LPL—type 2 diabetes mellitus	1.8e-06	0.00011	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—INS—type 2 diabetes mellitus	1.79e-06	0.00011	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-06	0.000109	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADCY5—type 2 diabetes mellitus	1.76e-06	0.000108	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—type 2 diabetes mellitus	1.75e-06	0.000107	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—type 2 diabetes mellitus	1.75e-06	0.000107	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—INS—type 2 diabetes mellitus	1.74e-06	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.73e-06	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.73e-06	0.000106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.73e-06	0.000106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.73e-06	0.000106	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD36—type 2 diabetes mellitus	1.71e-06	0.000104	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPP2CA—type 2 diabetes mellitus	1.68e-06	0.000103	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.66e-06	0.000102	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.66e-06	0.000102	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—type 2 diabetes mellitus	1.65e-06	0.000101	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.64e-06	0.0001	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.64e-06	0.0001	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.63e-06	9.98e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.63e-06	9.98e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—type 2 diabetes mellitus	1.62e-06	9.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.6e-06	9.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.6e-06	9.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.6e-06	9.81e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	9.76e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARA—type 2 diabetes mellitus	1.59e-06	9.7e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	9.62e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	9.62e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.57e-06	9.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.56e-06	9.51e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AGT—type 2 diabetes mellitus	1.54e-06	9.4e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	9.33e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	9.33e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.52e-06	9.29e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CALM1—type 2 diabetes mellitus	1.51e-06	9.24e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.51e-06	9.23e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—type 2 diabetes mellitus	1.51e-06	9.21e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-06	9.1e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.48e-06	9.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.45e-06	8.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.45e-06	8.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.45e-06	8.84e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—type 2 diabetes mellitus	1.44e-06	8.8e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—type 2 diabetes mellitus	1.41e-06	8.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.41e-06	8.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.41e-06	8.63e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.36e-06	8.34e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.36e-06	8.34e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.36e-06	8.34e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.36e-06	8.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.35e-06	8.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.31e-06	8.02e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.31e-06	8e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—type 2 diabetes mellitus	1.3e-06	7.97e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—INS—type 2 diabetes mellitus	1.29e-06	7.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.28e-06	7.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.28e-06	7.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.27e-06	7.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.24e-06	7.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.24e-06	7.61e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.23e-06	7.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.22e-06	7.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.19e-06	7.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.19e-06	7.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.19e-06	7.26e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—type 2 diabetes mellitus	1.18e-06	7.21e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.14e-06	6.96e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.14e-06	6.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.14e-06	6.94e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	6.9e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	6.9e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.11e-06	6.8e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.11e-06	6.8e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.1e-06	6.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.1e-06	6.7e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.09e-06	6.67e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.08e-06	6.63e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.08e-06	6.63e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.08e-06	6.63e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.08e-06	6.63e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.08e-06	6.59e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.08e-06	6.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.06e-06	6.47e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.06e-06	6.47e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.06e-06	6.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.06e-06	6.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.05e-06	6.39e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	6.31e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.95e-07	6.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.75e-07	5.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	9.72e-07	5.95e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	9.72e-07	5.95e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	9.72e-07	5.95e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	9.54e-07	5.84e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	9.46e-07	5.78e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.33e-07	5.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.32e-07	5.7e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	9.25e-07	5.66e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9e-07	5.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9e-07	5.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9e-07	5.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9e-07	5.5e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	8.89e-07	5.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	8.79e-07	5.38e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	8.79e-07	5.38e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.63e-07	5.28e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	8.57e-07	5.24e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.53e-07	5.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	8.43e-07	5.15e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	8.43e-07	5.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.02e-07	4.9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.49e-07	4.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.33e-07	4.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.33e-07	4.49e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.26e-07	4.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	7.26e-07	4.44e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	7.23e-07	4.42e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	7.23e-07	4.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.19e-07	4.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.15e-07	4.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.15e-07	4.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.15e-07	4.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	7.13e-07	4.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.1e-07	4.34e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	7.01e-07	4.29e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.98e-07	4.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	6.93e-07	4.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.9e-07	4.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	6.74e-07	4.12e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	6.67e-07	4.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	6.61e-07	4.04e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	6.47e-07	3.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	6.45e-07	3.95e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.41e-07	3.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.41e-07	3.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.41e-07	3.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.29e-07	3.85e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.28e-07	3.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.24e-07	3.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.21e-07	3.8e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.1e-07	3.73e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.95e-07	3.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.86e-07	3.59e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	5.84e-07	3.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.8e-07	3.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.8e-07	3.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	5.66e-07	3.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.56e-07	3.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.56e-07	3.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.56e-07	3.4e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.54e-07	3.39e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.48e-07	3.35e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	5.18e-07	3.17e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.83e-07	2.95e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.79e-07	2.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.79e-07	2.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.77e-07	2.92e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.74e-07	2.9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.71e-07	2.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.57e-07	2.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.44e-07	2.72e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.36e-07	2.67e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.34e-07	2.66e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.27e-07	2.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-07	2.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.15e-07	2.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.15e-07	2.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.14e-07	2.53e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.09e-07	2.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-07	2.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.85e-07	2.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.8e-07	2.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.73e-07	2.28e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.67e-07	2.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.66e-07	2.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.61e-07	2.21e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.18e-07	1.95e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.12e-07	1.91e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.86e-07	1.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-07	1.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-07	1.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-07	1.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-07	1.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-07	7.7e-06	CbGpPWpGaD
